GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MiMedx Group Inc (NAS:MDXG) » Definitions » Shiller PE Ratio

MiMedx Group (MiMedx Group) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2008. Start your Free Trial

What is MiMedx Group Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MiMedx Group Shiller PE Ratio Historical Data

The historical data trend for MiMedx Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MiMedx Group Shiller PE Ratio Chart

MiMedx Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MiMedx Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MiMedx Group's Shiller PE Ratio

For the Biotechnology subindustry, MiMedx Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MiMedx Group's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MiMedx Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MiMedx Group's Shiller PE Ratio falls into.



MiMedx Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MiMedx Group's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, MiMedx Group's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.385/129.4194*129.4194
=0.385

Current CPI (Dec. 2023) = 129.4194.

MiMedx Group Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.010 99.695 -0.013
201406 -0.004 100.560 -0.005
201409 0.030 100.428 0.039
201412 0.030 99.070 0.039
201503 0.040 99.621 0.052
201506 0.050 100.684 0.064
201509 0.060 100.392 0.077
201512 0.120 99.792 0.156
201603 0.010 100.470 0.013
201606 0.020 101.688 0.025
201609 0.030 101.861 0.038
201612 -0.057 101.863 -0.072
201703 0.040 102.862 0.050
201706 0.070 103.349 0.088
201709 0.150 104.136 0.186
201712 0.300 104.011 0.373
201803 0.040 105.290 0.049
201806 0.020 106.317 0.024
201809 -0.002 106.507 -0.002
201812 -0.340 105.998 -0.415
201903 -0.120 107.251 -0.145
201906 -0.160 108.070 -0.192
201909 0.110 108.329 0.131
201912 -0.070 108.420 -0.084
202003 -0.040 108.902 -0.048
202006 -0.080 108.767 -0.095
202009 -0.480 109.815 -0.566
202012 -0.170 109.897 -0.200
202103 -0.090 111.754 -0.104
202106 -0.030 114.631 -0.034
202109 -0.040 115.734 -0.045
202112 0.010 117.630 0.011
202203 -0.110 121.301 -0.117
202206 -0.110 125.017 -0.114
202209 -0.090 125.227 -0.093
202212 -0.020 125.222 -0.021
202303 -0.060 127.348 -0.061
202306 -0.005 128.729 -0.005
202309 0.060 129.860 0.060
202312 0.385 129.419 0.385

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MiMedx Group  (NAS:MDXG) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MiMedx Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MiMedx Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MiMedx Group (MiMedx Group) Business Description

Traded in Other Exchanges
N/A
Address
1775 West Oak Commons Court, NE, Marietta, GA, USA, 30062
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Executives
Rice Doug officer: Chief Financial Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Joseph H Capper officer: Chief Executive Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
Robert Benjamin Stein officer: EVP, Research and Development C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON MA 02421
Peter M Carlson officer: Chief Financial Officer BRIGHTHOUSE FINANCIAL, INC., 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
William Lawrence Phelan officer: Chief Accounting Officer 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Hulse William Frank Iv officer: General Counsel 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Ricci S Whitlow officer: Chief Operating Officer C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rohit Kashyap officer: EVP & Chief Commercial Officer 8023 VANTAGE DRIVE, SAN ANTONIO TX 78230
Timothy R Wright director, officer: Chief Executive Officer C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Mark Graves officer: SVP & Chief Compliance Officer 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062
Scott M Turner officer: SVP, Operations & Procurement 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062
Phyllis Gardner director 618 MIRADA AVENUE, STANFORD CA 94305
Michael J Giuliani director 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Cato T Laurencin director C/O UNIVERSITY OF CONNECTICUT, 263 FARMINGTON AVENUE, FARMINGTON CT 06030-3800
William A Hawkins director MEDTRONIC INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604

MiMedx Group (MiMedx Group) Headlines